We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

8 hedge funds and large institutions have $515K invested in NeuroMetrix, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

39% more capital invested

Capital invested by funds: $371K → $515K (+$144K)

14% more funds holding

Funds holding: 7 → 8 (+1)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$193K
2
Renaissance Technologies
Renaissance Technologies
New York
+$75.6K
3
Macquarie Group
Macquarie Group
Australia
+$58.8K
4
OFS
Orrstown Financial Services
Pennsylvania
+$19.6K
5
UBS Group
UBS Group
Switzerland
+$988

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$43K
2
Morgan Stanley
Morgan Stanley
New York
-$31K

NURO Hedge Fund Activity: Q3 2017 in Review

8 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2017, worth a combined $515K — up 39% from $371K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NURO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $193K. The largest seller was Goldman Sachs, exiting entirely with an estimated $43K sold.

  • 8 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2017, up from 7 in Q2 2017.
  • Funds reported $515K of NeuroMetrix, Inc. Common Stock stock for Q3 2017, up 39% quarter-over-quarter.
  • 4 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2017 and 2 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2017 was Sabby Management, an estimated $193K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2017 was Goldman Sachs, an estimated $43K sold.

Based on aggregated 13F filings for Q3 2017.